Shivkumar Hatti
Psychiatry · Media, PANPI 1841297975
Payments from drug & device makers
Across 828 payments — averaging $4849.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$1.2M
- AbbVie$713K
- Janssen Research & Development, LLC$557K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$484K
- Vertex$173K
- Supernus Pharmaceuticals, Inc.$151K
- plus $725K from 23 others
Across 6 payments — averaging $383.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$2K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$422
- AbbVie$155
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 18 | $1,211,991 |
| AbbVie(2 entities) | 148 | $713,303 |
| Janssen Research & Development, LLC | 136 | $557,130 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 98 | $484,206 |
| Vertex | 3 | $172,504 |
| Supernus Pharmaceuticals, Inc. | 31 | $151,018 |
| Acadia Pharmaceuticals Inc | 91 | $122,911 |
| Merck | 4 | $91,565 |
| Teva Pharmaceuticals USA, Inc. | 44 | $88,217 |
| Corcept Therapeutics | 26 | $71,378 |
| Johnson & Johnson | 97 | $63,466 |
| F. Hoffmann-la Roche AG | 25 | $56,423 |
| Avanir Pharmaceuticals, Inc. | 24 | $36,661 |
| Jazz Pharmaceuticals Inc. | 4 | $35,565 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $35,521 |
| Boehringer Ingelheim | 1 | $22,500 |
| Novo Nordisk AS | 12 | $22,498 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $16,139 |
| Eisai Inc. | 5 | $10,655 |
| Eli Lilly | 5 | $9,746 |
| Biohaven Pharmaceuticals, Inc. | 5 | $9,391 |
| Sunovion Pharmaceuticals Inc. | 4 | $8,133 |
| Biogen | 1 | $7,500 |
| E.r. Squibb & Sons, L.L.C. | 2 | $5,015 |
| Boehringer Ingelheim International GmbH | 11 | $4,136 |
| Pfizer | 3 | $3,534 |
| GRT US Holding, Inc. | 3 | $3,500 |
| Shionogi Inc | 1 | $395 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
How this compares
$4,015,027 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Media
- Kristen DopfMedia$88K
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.